Epidemiology of Osteoporosis in Patients with Type 1 Diabetes Mellitus by Khalid S Aljabri in Archives of Diabetes & Obesity in Lupine Publishers
Background and Objective: The incidence of type 1 diabetes is increasing. Osteoporosis has become an alarming health
problem throughout the entire world. The aim of this study were to estimate the epidemiology of osteoporosisamong Saudi patients
with T1DM, living in the western province, attending the diabetes centre at King Fahd Armed Forces Hospital, Jeddah, KSA.
Methods: Eligible patients were older than 12 years old, had
T1DM . All patients were recruited from the population of the
Diabetic Centre at King Fahad Armed Forces Hospital. Eligible patients
met with investigators for a complete history and physical
examination, to have baseline laboratory assessments including
glycosylated haemoglobin (HbA1c). HbA1c was expressed as
percentage and measured using the high-performance liquid
chromatography. BMD in the current study was measured using The
Lunar Achilles (In Sight, GE Healthcare, USA), which is a proven bone
ultrasonometer to avoid exposing the children to unnecessarily
ionizing radiation. All measurements were converted to Z-scores using a
data bank for age-matched speed of sound values supplied
by the manufacturer. We excluded patients with a history of fractures of
less than 1 year and those with associated bone/joint
problems, liver disease or patients on long-term steroid therapy
Main results: 137 patients completed the study. There were 60
(44%) male and 77 (56%) were female with mean age 19.1±4.9.
Osteoporosis was found in 53 of cases (38.7%) of patients. There were 23
(43.4%) male and 30 (56.6%) were female giving a female
to male ratio 1.3:1. Osteoporosis was found in 53 of cases (38.7%) of
patients. Baseline characteristics are shown in Table 1. Patients
with osteoporosis were significantly younger, longer diabetes duration and have higher HbA1c than patients without osteoporosis.
Osteoporosis was higher in females than male and was seen more in cases
with HbA1c > 9.0 as compared to HbA1c groups of < 8.0
and 8-9, (Figures 1 & 2). Cases with longer diabetes duration
(≥6years) have nonsignificant more frequent osteoporosis than cases
with diabetes duration < 6 years, 34% vs. 66% respectively, p=0.4.
There were no significant differences between genders and
frequency of osteoporosis in relation to diabetes duration.
Conclusion: Our findings demonstrate lower BMD in young women with type 1 diabetes. Although bone density testing is not
routinely performed in young women, these data suggest that screening may be important in young women with type 1 diabetes.
In addition, these women should be counseled regarding lifestyle interventions that may improve bone health, including adequate
intake of calcium and vitamin D, and exercise.
For more Diabetes Obesity Journal open access journalarticles please click here
No comments:
Post a Comment